gmp-verlag.de
 

Never ever a 483?

We can not promise that you will never get a 483
but we know that the GMP MANUAL includes all 
procedures and processes you need to be
GMP compliant.
 
Stay informed!

If you’d like to be regularly informed of the latest developments at Good Manufacturing Practices

 

>>> simply register for our free GMP newsletter LOGFILE

 
 

Image

 
 
GMP Subject Downloads

BESTSELLER

1. GMP Audit Checklist
for Pharmaceutical and API Manufacturers

 

2. Documenting Process Validation
A Drugmaker‘s Guide – step-by-step manual based on real-world examination experience

 

3. Computer System Validation in the EU
a step-by-step guide to implementing a computer validation program

 

4. GDP Audit Checklist
for the Storage and Transport of Pharmaceuticals

 

5. GMP Compliant Documentation
how to create, organize, review and archive GMP related documents

 

Your benefits:

> no shipping costs
> no waiting period: if you choose payment by credit card you will receive an email with the download information immediately after payment.

 

>>> Click here to see all GMP Subject Downloads!

 

News about GMP/cGMP

WHO Report: Inspections of API Manufacturers

Recently the WHO (World Health Organization) issued the first "Pharmaceuticals Newsletter" in 2011. It contains an interesting Report on WHO Inspection Activites of API (Active Pharmaceutical Ingredients) Manufacturers.

 

API manufacturing site inspections were started in 2003. An inspection team normally consists of a WHO inspector based in Geneva and a co-inspector appointed by the WHO from a Pharmaceutical Inspection Cooperation Scheme (PIC/S) member inspectorate. An inspector (or inspectors) from the National Drug Regulatory Authority of the country, in which the manufacturing site is located is invited to participate as an observer.

Statistics

Out of 126 API sites participating in PQ activities, 49 were accepted based on approval by PICS inspectorates and/or ICH countries, while 31 were inspected by WHO inspectors. Six of the inspected sites were found to operate at an unacceptable level of compliance with WHO GMP.

Key Observations of API inspections

Deficiencies observed during inspections of API sites have been mainly in materials management, documentation, cleaning and cross-contamination.

Outcome:

You can download the WHO "Pharmaceuticals Newsletter", Issue 1/ 2011. You find the complete report at page 12 et seqq.

Link:

WHO/ Newsletter

Comments
No comment have jet been written about this news
 
 

Maas & Peither AG
GMP Publishing

Karlstraße 2
79650 Schopfheim
Germany

E-Mail: service@gmp-verlag.de
Tel. +49 (0) 7622 6 66 86 70
Fax +49 (0) 7622 6 66 86 77